Development of autoimmunity in patients with common variable immune deficiency

Common variable immune deficiency (CVID) is a genetic disease associated with enhanced susceptibility to infection, autoimmunity, and decreased antibody production. Mutations in the tumor necrosis factor receptor superfamily member TACI, are associated with CVID and autoimmunity development. Interestingly, autoimmunity develops in CVID patients with only one mutated copy of TACI, and CVID patients with two mutated TACI alleles do not develop autoimmunity.

In this issue of the Journal of Clinical Investigation, Eric Meffre and colleagues at Yale University evaluated B cell activation and tolerance development in healthy individuals and CVID patients with one or two mutated copies of TACI. The authors found that CVID patients with a single altered TACI allele maintained some residual B cell responsiveness that promoted development of autoantibodies, whereas individuals with 2 mutated copies of TACI have complete impairment of B cell responses, which likely prevents autoimmunity.

In the companion commentary, Antonia La Cava of the University of California Los Angeles suggests that targeting residual B cell activity in CVID patients that are heterozygous for TACI mutations may provide clinical relief.

More information: CVID-associated TACI mutations affect autoreactive B cell selection and activation, J Clin Invest. DOI: 10.1172/JCI69854

Related Stories

Body's 'safety procedure' could explain autoimmune disease

date Sep 05, 2013

Monash University researchers have found an important safety mechanism in the immune system that may malfunction in people with autoimmune diseases, such as Multiple Sclerosis, potentially paving the way for innovative treatments.

New drug target for immune diseases discovered

date Aug 03, 2010

Researchers from Mount Sinai School of Medicine have found a new mechanism that explains how certain immune cells are activated to create protective antibodies against infections or pathological antibodies such as those present ...

Recommended for you

Novel algorithm can classify chronic rhinosinusitis

date May 21, 2015

(HealthDay)—A novel scoring system and algorithm can be used to classify eosinophilic chronic rhinosinusitis (ECRS) by disease severity, according to a study published online May 6 in Allergy.

Shining a new light on the immune system

date May 21, 2015

Scientists at the University of St Andrews have developed a revolutionary method of identifying cells of the immune system with "molecular fingerprints" which could pave the way for the rapid detection of ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.